Navigation Links
Stereotaxis Highlights Live Coronary and Peripheral Vascular Cases Performed at TCT With Stereotaxis Magnetic Navigation System
Date:10/25/2007

rformed by Dr. Mark Reisman of the

Swedish Heart and Vascular Institute, during which he used the

Stereotaxis system to produce a 3D vascular map and successfully cross

a subclavian stenosis to permit stent deployment. A prior two-hour

conventional percutaneous intervention of this patient was unsuccessful

due to extreme vessel tortuosity and larger vessel diameter. However,

crossing of the subclavian lesion with a Stereotaxis 3D vessel roadmap

and magnetic guidewire tip guidance was accomplished in less than 10

seconds of wiring time.

"The Stereotaxis Magnetic Navigation platform enabled our procedure significantly by facilitating the passage of wires in complex peripheral anatomy," said Dr. Reisman. "This patient benefited by the reduced procedure time and contrast load, and resulted in the minimizing of potential complications to the neurovascular circulation."

"We are very pleased that these three patients were able to receive the treatment they needed, and that all are recovering well," said Bevil Hogg, CEO of Stereotaxis. "Their procedures demonstrate the clinical value of Stereotaxis' 3D vessel roadmaps and distal tip control of magnetic guidewires in the treatment of complex coronary and peripheral vasculature disease. We believe that Stereotaxis' advanced coronary and peripheral navigation capabilities can bring a new level of simplicity, safety and precision to a variety of vascular interventions, and we were proud that leading cardiologists chose to use our technology in live cases at TCT."

At TCT, Stereotaxis showcased the interventional cardiology capabilities of its Stereotaxis Magnetic Navigation System, which include CTO vessel road mapping and image integration, as well as the global connectivity capabilities of its Odyssey(TM) Network Solutions. In the "Cath Lab of the Future," which was sponsored by TCT, the company demonstrated important advances in vascular
'/>"/>

SOURCE Stereotaxis, Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine news :

1. Chennai AIDS Campaign Highlights The Social Neglect Faced By Victims
2. Benzene Slick In China Highlights Water Pollution
3. Homecare Association Highlights Cost-Effectiveness of Medicare and Medicaid
4. Study Highlights Appetite Regulation Pathway, New Hope for Weight Loss
5. Study Highlights How Bacteria Respond To Changes In Environment
6. Highlights from World Transplant Congress
7. Latest IPCC Report Highlights Need for Integrated Climate/human Behavior Models
8. New Critical Path Report Highlights Research Needed to Foster Generic Drug Development
9. New York Legislature Highlights for Awareness of Alzheimers Disease
10. New Critical Path Report Highlights Research Needed to Foster Generic Drug Development
11. EU Drug Regulator Highlights Depression Danger of Weight-loss Pill
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine Technology:Allos Therapeutics' PDX Granted Orphan Medicinal Product,Designation by the European Commission 2Allos Therapeutics' PDX Granted Orphan Medicinal Product,Designation by the European Commission 3Allos Therapeutics' PDX Granted Orphan Medicinal Product,Designation by the European Commission 4Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 2Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 3Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 4Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 5Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 6Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 7Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 8